Next Article in Journal
Podcasts as a Method to Deliver Education on Stigma Surrounding Opioid Use Disorder
Next Article in Special Issue
Medication-Related Outcomes and Health Equity: Evidence for Pharmaceutical Care
Previous Article in Journal
Impact of Clinical Pharmacy Expansion within a Rural Federally Qualified Health Center through Implementation of Pharmacist-Led Medicare Annual Wellness Visits
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Home Drug Delivery Service from the Perspective of Community Pharmacy Staff in Saudi Arabia

by
Majed Ahmed Algarni
*,
Mona Yaser Alsheikh
,
Ahmed Ibrahim Fathelrahman
,
Meshal Suwaylih Alzaidi
,
Fawaz Jilan Faqeeh
,
Abdulelah Mohammad Althobaiti
and
Ali Mofleh Alshahrani
Department of Clinical Pharmacy, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
*
Author to whom correspondence should be addressed.
Pharmacy 2022, 10(6), 162; https://doi.org/10.3390/pharmacy10060162
Submission received: 3 October 2022 / Revised: 17 November 2022 / Accepted: 25 November 2022 / Published: 29 November 2022
(This article belongs to the Special Issue Delivery of Pharmaceutical Care—Leaving No One Behind)

Abstract

:
Background: In response to COVID-19, many big pharmacy chains in Saudi Arabia have started to provide home drug delivery services. This study aims to understand home drug delivery service from the perspective of community pharmacists in Saudi Arabia. Also, the study investigates the obstacles that may limit the use of home drug delivery service. Methods: A cross-sectional self-reported survey was distributed from February 2021 to May 2021. Descriptive analysis of sociodemographic characteristics was conducted and presented. Frequencies and percentages were calculated for all variables. Results: A total of 965 community pharmacists were surveyed. Most of the pharmacists, (73.5%) were young, aged 23 to 34 years old. The vast majority of the participants, (93.6%), said that the service will improve drug adherence. The lack of required knowledge and skills among pharmacists could be the main obstacle to implement home drug delivery service (34%). A shortage in the number of community pharmacists was the second main obstacle (24%). Conclusion: Home delivery services in the future may largely replace the tradition of going in person to the pharmacy. There are obstacles that may limit the full use of the service like shortage in number of pharmacists and the lack of required training.

1. Introduction

Until recently, dispensing medications was the dominant service provided by community pharmacies in Saudi Arabia [1]. However, the new Saudi government vision [2] and the need for other services are pushing community pharmacies to develop their services and to include new improved alternatives for patients, such as drug delivery services [3]. The need for and importance of home delivery services was substantially notable during the COVID-19 pandemic [4]. In Saudi Arabia, people could not get out of their homes due to the government-mandated quarantine that was issued for many months following the outbreak of the pandemic. Consequently, pharmacies were urged to provide home delivery services. The large chain pharmacies in Saudi Arabia started their home delivery services at that time and continued with the delivery service even when the quarantine was lifted. Public hospitals and health centers organized drug delivery services during the mandated quarantine. Patients need home care services not only in times of pandemics and quarantines but also in normal situations, especially, geriatric patients, patients with disabilities, or those with chronic illnesses [5]. Pharmaceutical delivery services may facilitate patient accessibility to medications, ensuring drug adherence, which in turn improve public health and the whole healthcare system [6]. The role of the pharmacist has traditionally been restricted to prepare, and dispense medicines [7], however, the pharmacy profession has evolved in the last few decades to improve patient outcomes and contribute to the advancement of health care system. In developing countries such as Saudi Arabia, national efforts are often directed towards ensuring the availability of and accessibility of drugs for all patients [8]. Nevertheless, community pharmacy roles are expanding in Saudi Arabia, and the new governmental vision is accelerating the expansion process [2]. Examples of expanded roles established recently in community pharmacies are the provision of COVID-19 vaccines and the management of patients with chronic diseases. Drug delivery services have been used in many countries for years, and have been a helpful tool in reducing the costs. For instance, in the USA, the mail service helped to decrease the total costs of prescriptions [9,10]. Recently, in Saudi Arabia, the Saudi Postal Services & Logistics (SPL) and the Ministry of Health (MOH) signed an agreement to deliver medications to patients who are treated in MOH hospitals and health centers at their homes, where the agreement aims to cover 284 hospitals and medical centers in various regions [11]. To date, a million drug deliveries have been made. The beneficiaries are normally patients receiving refills and when new patients are included in the services they get an appointment with a virtual pharmacy-led clinic to receive the required education before being covered by the medication delivery services. On the other hand, Alnahdi Medical Company, a private operator of one of the largest series of community pharmacies in Saudi Arabia, adopted three packages of services, with one for home medication delivery, one for medication adherence, and another for elderly patients where nurses and other healthcare providers provide home care for the elderly patients with chronic diseases. Pharmacists are involved directly in the medication adherence services by providing counseling and performing assessment of adherence among patients. The delivery service is normally provided separately to the pharmacy, but occasionally pharmacy technicians may be involved in the delivery process. In this study, our objective is to comprehend and highlight the understanding and attitudes of pharmacists in Saudi Arabia regarding drug delivery services. Since pharmacists are the ones who dispense medications for patients, educate patients about their medications, and communicate with patients in many levels, it is imperative to know more about their view and understanding regarding drug delivery service.

2. Materials and Methods

We implemented a cross-sectional self-reported survey to assess drug delivery services provided by community pharmacy staff. The survey questions were specifically designed for the purpose of the current study. Two staff from College of Pharmacy, Taif University, with good practice- and research-based experiences validated the questionnaire. The reviewer feedback was used to edit the survey as needed. A pilot sample from community pharmacy staff was used to test the survey’s appropriateness, including easiness, clarity, and the required time for completion. We adopted a convenience sampling technique to recruit community pharmacy staff between February 2021 and May 2021. In Saudi Arabia, there were 8419 community pharmacists out of 24,395 licensed pharmacists (34.5%) working in different pharmacy sectors [12]. For this study, it was determined that surveying at least 842 pharmacy staff from different regions across Saudi Arabia would be representative (i.e., 10%). The self-reported survey was distributed to both individual pharmacies and to groups of chain pharmacies. The link to the survey was delivered via social media such as WhatsApp groups and Twitter. Some keypersons facilitated the communication with participants. All participants were provided with informed consent. In line with the ethical research requirements guiding this study, all data were collected anonymously with no personally identifiable information about the participants being collected. An approval from the Scientific Research Ethics Committee at Taif University was obtained with the number HAO-02-T-105. The survey was divided into two sections. The first section was about the demographic profile for the community pharmacist, for example, gender, age, educational level, monthly income, the region the pharmacist lives in, professional classification. The survey tool was used for assessing drug delivery services from the perspective of community pharmacists. Descriptive analysis of sociodemographic characteristics is conducted and presented here. Frequencies and percentages were calculated for all variables. Microsoft Excel® version 16.53 was used to clean, sort, and analyze the data.

3. Results

A total of 965 licensed pharmacy staff participated in the survey. The participants were from all different regions of Saudi Arabia. Most of them (88.5%, n = 854) were male, whereas only (11.5%, n = 111) were female. Most of participants were aged 23–34 years old (73.6%), followed by those aged 35–44 years old (22.2%). Only a fourth of the sample were Saudis (n = 239, 24.7%), while 726 were non-Saudi (75.2%). Respondents from the western region of Saudi Arabia represents the majority with 401 participants (41.5%), while the eastern region was the least represented by only 81 participants (8%). Most of the participants (n = 800, 82.9%) were holding a Bachelor’s degree, 127 with a PharmD (13%), and only 27 have a MSc or PhD (2.7%). By professional classification (i.e., according to Saudi Commission for Health Specialties), the highest proportion were pharmacists (70.2%), followed by senior pharmacists (25.6%), consultant pharmacists (3.2%), and finally, pharmacy technicians (1.1%). The vast majority of pharmacy staff work in chain pharmacies (n = 895, 92.7%), and few work in independent pharmacies (7%). Only 101 out of 965 participants said they are not satisfied with their job (10%). About two thirds (n = 616, 64%) have an experience for more than 5 years. Table 1 below provides a summary of the demographics of the participants.
Most of the surveyed community pharmacy staff (n = 689, 71.4%) agreed that drug delivery helps patients to continue taking their medication, while only 61 (6%) disagreed about that (Table 2). Out of 965 surveyed pharmacists, 91% (n = 879) think that pharmacists can provide remote consultation if there is a consulting application, while the other 9% (n = 86) disagreed about that. More than half of the surveyed pharmacists (61%, n = 586) also agreed that pharmacists can monitor the health of patients with chronic conditions in their homes, while 39% (n = 379) disagreed. Most of the surveyed pharmacy staff (81.4%, n = 786) believe that delivery apps would become a substitute for going to the hospital to collect treatment, whereas the rest (18.5%, n = 179) did not believe that drug delivery would substitute going to a hospital for collecting medications (Table 2). Around 73% (702 out of 965) of the surveyed respondents chose respiratory system diseases to be among the most diseases that pharmacists need to be educated about for drug delivery service (Table 2). Of the surveyed pharmacists, 884 community pharmacists preferred to sell medications directly inside the pharmacy (92%), while 81 pharmacists preferred to sell them online (8%). The highest proportion (n = 688, 71.3%) of the surveyed respondents think that pharmacists are the most qualified to deliver home drug delivery. When asked whether they support pharmacist to charge a fee for providing delivery services, 72% (n = 689) of the respondents said “yes”, while 28% (n = 267) chose “no” as answer for that question (Table 2). The surveyed community pharmacists when asked about the obstacles that may limit implementing home drug delivery service, 57.6% chose time, 34.8% chose the lack of the required knowledge and skills, 27.3% chose that shortage in number of community pharmacists could be the main obstacle, 37.9% said that the lack of coordinated and supportive policies might be the main obstacle, 23.8% said that patients’ unwillingness to use home drug delivery service could be the main obstacle, and 23.2% said that lack of required pharmacist’ confidence and good training is the main obstacle (Figure 1).

4. Discussion

Community pharmacy roles have increased in the last few decades. They have become more than a dispensing place, also a substantial player in the health care system, with a range of different services. Among the services adopted by community pharmacies recently, in Saudi Arabia, delivery services are particularly clinically oriented services that help with ensuring patient health outcomes. To the best of our knowledge, this is the first study that has studied drug delivery service from the perspective of community pharmacists in Saudi Arabia. In total, 965 community pharmacists participated in this study. Most of the participating pharmacists agreed that drug delivery services would improve patient drug adherence. This result coincides with many previous published studies that were done in countries with drug delivery service, in which, the results showed that delivery service increased drug adherence for treating chronic diseases like diabetes [13,14,15,16,17]. As a logistical service, drug delivery helps patients receive their medication on time, thus, to maintain treatment and have better health indicators. The majority of the surveyed community pharmacists (91%) agreed that proper and necessary consultation could be done remotely. This result matched with many published articles that approved both the importance and the success of remote consultation, especially in pandemic situations like COVID-19, where the most precautionary measures should be taken [18,19,20]. Moreover, 81% of the surveyed pharmacists agreed that home delivery services would largely replace the old tradition of going in person to a pharmacy to receive or refill the prescribed medications. Findings in a recently published article showed that home delivery services and telepharmacies are some of the most important factors that represent a major shift in pharmacy practice, especially in the context of COVID-19 [21]. Further, a study that was conducted in Spain found that the majority of patients used home delivery services since the COVID-19 pandemic started [22]. Studies conducted in the eastern region of Saudi Arabia found that ambulatory pharmacy services were well sustained via home delivery services [23,24]. This shift of pharmacy practice toward home delivery and telepharmacy care may not get slower, even if the COVID-19 pandemic is resolved, since most people, especially elderly patients or those with special needs, or even normal people, may depend more and more on such services, since it is easier and more comfortable than the traditional service. This can be viewed as an innovation and a positive change in pharmacy practice; however, it also represents a challenge to pharmacy personnel in the future and the pharmacy profession should keep advancing its provided services to stay at the frontlines of healthcare. Literature from the Arabic region has highlighted the pros and cons of home drug delivery from the perspectives of both pharmacists and the public. In Jordan, three thirds of community pharmacists surveyed supported the use of home medication delivery [25]. However, half of the respondents in this study think that such a service is suitable for refill prescriptions and not for new prescriptions. One of the benefits identified by pharmacists was that these services decrease congestion at health facilities. Another study from Jordan revealed supportive findings among the public [26]. Participants tend to believe that home delivery of medication is more convenient and accessible than in-store drug refills and most of them believed that such services are more suitable for refill-prescription drugs. A study from Lebanon investigated perceptions of the public regarding home medication delivery [27]. Participants thought that home delivery would negatively affect pharmaceutical care since it makes pharmacists less accessible for answering patient questions and prevents pharmacists from explaining important information about medications. On the other hand, as expected, the majority of the surveyed community pharmacists in our study (72%) said that those pharmacists who prepare and supervise delivery services deserve an extra fee for their services. Only 28% indicated that it is not necessary to have an extra fee. A considerable portion of the surveyed pharmacists (19%) considered that a lack of coordinated and supportive polices is one of the main challenges that may hinder home delivery services. Two recently published articles coincide with such results, which agree that excellent communication and coordination between the different involved sectors in home delivery services is a key factor in ensuring a good service [28,29]. Another 10% of the participated pharmacists said that lack of appropriate training, like communication skills, is the main obstacle, which also coincides with previous published studies’ results [28,29]. Females represented a small proportion of participants. However, according to previous reports this low representation reflects the actual situation of practice at community pharmacy at the time of study. For example, AlRuthia et al., reported that females represented only 14.84% of licensed pharmacy workforce working in different settings of practice in Saudi Arabia [12]. Knowing that the community pharmacy was not the preferred setting for practice among female pharmacists, most were working in hospitals, industry, and regulatory sectors. Almaghaslah and associates also reported that community pharmacists constitute 74.5% of the pharmacy workforce in the private sector in Saudi Arabia and that females account for 0.3% [30]. To our knowledge, this is the first study documenting home drug delivery in Saudi Arabia on a national scope. The strengths of the present study are the relatively large sample size and presence of representation from all regions across Saudi Arabia. A limitation of study was that the regions of Saudi Arabia were not equally represented in the study, with the majority of pharmacists being located in the western region. Another limitation is that rural pharmacists were a minority in the study. This study addressed home drug delivery services from the perspective of community pharmacy staff. The findings represent how respondents perceive the importance and value of such services and do not assess the actual practice. However, they are a good baseline for future studies on the topic.
Improving health care systems to provide high quality and cost-effective healthcare services to treat a needy population could be a challenge, and home drug delivery services could play a part to improve such a healthcare system. Previous studies have shown that home delivery services provided by community pharmacies may play a role in decreasing the costs of the health system, improving medication management, reducing emergency department visits and hospital admissions, and improving the overall quality of life.

5. Conclusions

This study shows that community pharmacy staff believe that drug delivery services will improve medication compliance. Respondents who participated in this study gave a clear vision about their expectations about home delivery services provided by community pharmacies in Saudi Arabia. In the future, home delivery services may largely replace the tradition of in-person pharmacy visits. However, according to the surveyed community pharmacists, there are obstacles that limit the full use of such services, like a shortage in number of pharmacists and the lack of required training. These obstacles should be eliminated to allow the full benefit of home drug delivery services.

Author Contributions

Conceptualization, M.Y.A. and A.M.A. (Ali Mofleh Alshahrani); methodology, F.J.F. and A.M.A. (Abdulelah Mohammad Althobaiti); validation, A.I.F., M.A.A. and A.M.A. (Abdulelah Mohammad Althobaiti); formal analysis, M.Y.A.; investigation, A.I.F.; writing—original draft preparation, M.S.A. and M.Y.A.; writing—review and editing, M.S.A.; supervision, A.M.A. (Ali Mofleh Alshahrani); project administration, A.M.A. (Ali Mofleh Alshahrani). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Scientific Research Ethics Committee of Taif University (No. HAO-02-T-105).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are available upon reasonable request to the corresponding author.

Acknowledgments

The authors of this work would like to acknowledge the valuable assistance from Mohammed Alshennawi, General Director, General Administration of Pharmaceutical Care, Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia, who provided valuable information on home medication delivery service implemented by the Saudi Ministry of Health.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Alanazi, A.S.; Alfadl, A.A.; Hussain, A.S. Pharmaceutical Care in the Community Pharmacies of Saudi Arabia: Present Status and Possibilities for Improvement. Available online: https://www.sjmms.net/article.asp?issn=1658-631X;year=2016;volume=4;issue=1;spage=9;epage=14;aulast=Alanazi (accessed on 2 July 2021).
  2. Kingdom of Saudi Arabia Vision 2030. Available online: https://www.vision2030.gov.sa/ (accessed on 2 July 2021).
  3. Walus, A.N.; Woloschuk, D.M.M. Impact of Pharmacists in a Community-Based Home Care Service: A Pilot Program. Can. J. Hosp. Pharm. 2017, 70, 435–442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Bejarano, A.P.; Santos, P.V.; Robustillo-Cortés, M.D.L.A.; Gómez, E.S.; Rubio, M.D.S. Implementation of a novel home delivery service during pandemic. Eur. J. Hosp. Pharm. 2020, 28, e120–e123. [Google Scholar] [CrossRef] [PubMed]
  5. Whitty, J.A.; Kendall, E.; Sav, A.; Kelly, F.; McMillan, S.S.; King, M.A.; Wheeler, A.J. Preferences for the delivery of community pharmacy services to help manage chronic conditions. Res. Soc. Adm. Pharm. 2015, 11, 197–215. [Google Scholar] [CrossRef] [Green Version]
  6. Feehan, M.; Walsh, M.; Godin, J.; Sundwall, D.; Munger, M.A. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study. J. Clin. Pharm. Ther. 2017, 42, 738–749. [Google Scholar] [CrossRef] [PubMed]
  7. Blouin, R.A.; Adams, M.L. The Role of the Pharmacist in Health Care: Expanding and Evolving. North Carol. Med. J. 2017, 78, 165–167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Cameron, A.; Roubos, I.; Ewen, M.; Mantel-Teeuwisse, A.K.; Leufkens, H.G.; O Laing, R. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull. World Health Organ. 2011, 89, 412–421. [Google Scholar] [CrossRef]
  9. Clark, B.E.; Siracuse, M.V.; Garis, R.I. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans. Res. Soc. Adm. Pharm. 2009, 5, 133–142. [Google Scholar] [CrossRef] [PubMed]
  10. Ma, J.; Wang, L. Characteristics of Mail-Order Pharmacy Users: Results from the Medical Expenditures Panel Survey. J. Pharm. Pract. 2020, 33, 293–298. [Google Scholar] [CrossRef]
  11. Ministry of Health Saudi Arabia. Available online: https://www.moh.gov.sa/en/Pages/Default.aspx (accessed on 2 July 2021).
  12. Alruthia, Y.; Alsenaidy, M.A.; Alrabiah, H.K.; AlMuhaisen, A.; AlShehri, M. The status of licensed pharmacy workforce in Saudi Arabia: A 2030 economic vision perspective. Hum. Resour. Health 2018, 16, 1–8. [Google Scholar] [CrossRef] [PubMed]
  13. Schmittdiel, J.A.; Marshall, C.J.; Wiley, D.; Chau, C.V.; Trinacty, C.M.; Wharam, J.F.; Duru, O.K.; Karter, A.J.; Brown, S.D. Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: A qualitative study. BMC Health. Serv. Res. 2019, 19, 422. [Google Scholar] [CrossRef] [PubMed]
  14. Schmittdiel, J.A.; Karter, A.J.; Dyer, W.; Parker, M.; Uratsu, C.; Chan, J.; Duru, O.K. The Comparative Effectiveness of Mail Order Pharmacy Use vs. Local Pharmacy Use on LDL-C Control in New Statin Users. J. Gen. Intern. Med. 2011, 26, 1396–1402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Duru, O.K.; A Schmittdiel, J.; Dyer, W.T.; Parker, M.M.; Uratsu, C.S.; Chan, J.; Karter, A.J. Mail-order pharmacy use and adherence to diabetes-related medications. Am. J. Manag. Care 2010, 16, 33–40. [Google Scholar] [PubMed]
  16. Devine, S.; Vlahiotis, A.; Sundar, H. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J. Med. Econ. 2010, 13, 203–211. [Google Scholar] [CrossRef]
  17. Fernandez, E.V.; McDaniel, J.A.; Carroll, N.V. Examination of the Link Between Medication Adherence and Use of Mail-Order Pharmacies in Chronic Disease States. J. Manag. Care Spec. Pharm. 2016, 22, 1247–1259. [Google Scholar] [CrossRef] [PubMed]
  18. Barnett, N.; Jubraj, B. Remote Consultations: How Pharmacy Teams can Practise Them Successfully. The Pharmaceutical Journal. Available online: https://pharmaceutical-journal.com/article/ld/remote-consultations-how-pharmacy-teams-can-practise-them-successfully (accessed on 28 July 2021).
  19. Ameri, A.; Salmanizadeh, F.; Bahaadinbeigy, K. Tele-pharmacy: A new opportunity for consultation during the COVID-19 pandemic. Health Policy Technol. 2020, 9, 281–282. [Google Scholar] [CrossRef]
  20. Agnew, J.; Alicehajic-Becic, D.; Barnett, N.; Crawford, P.; Darcy, C.; Jones, E.; McKee, H.; Miller, K.; Oboh, L.; Smith, H. Optimising remote consultations for older people during COVID-19. Prescriber 2021, 32, 9–14. [Google Scholar] [CrossRef]
  21. Nadeem, M.F.; Samanta, S.; Mustafa, F. Is the paradigm of community pharmacy practice expected to shift due to COVID-19? Res. Soc. Adm. Pharm. 2021, 17, 2046–2048. [Google Scholar] [CrossRef] [PubMed]
  22. Tortajada-Goitia, B.; Morillo-Verdugo, R.; Margusino-Framiñán, L.; Marcos, J.A.; Fernández-Llamazares, C.M. Survey on the situation of telepharmacy as applied to the outpatient care in hospital pharmacy departments in Spain during the COVID-19 pandemic. Farm. Hosp. 2020, 44, 135–140. [Google Scholar] [CrossRef] [PubMed]
  23. Thorakkattil, S.A.; Nemr, H.S.; Al-Ghamdi, F.H.; Jabbour, R.J.; Al-Qaaneh, A.M. Structural and operational redesigning of patient-centered ambulatory care pharmacy services and its effectiveness during the COVID-19 pandemic. Res. Soc. Adm. Pharm. 2021, 17, 1838–1844. [Google Scholar] [CrossRef] [PubMed]
  24. AlAbbasi, H.K.; A Thorakkattil, S.; I Mohiuddin, S.; Nemr, H.S.; Jabbour, R.; Al-Ghamdi, F. Implementation and effectiveness of drive-through medication pick-up and home delivery services. A patient safety initiative during COVID-19 pandemic. J. Patient Saf. Risk Manag. 2021, 26, 179–186. [Google Scholar] [CrossRef]
  25. Abu-Farha, R.; Alzoubi, K.H.; Alkhawaldeh, R.; Itani, R.; Karout, S.; Mukattash, T.; Alefishat, E. Home delivery of medications: Community pharmacists’ perspectives on the pros and cons of the service. Front. Public Health 2022, 10, 966145. [Google Scholar] [CrossRef] [PubMed]
  26. Abu-Farha, R.; Alzoubi, K.H.; Rizik, M.; Karout, S.; Itani, R.; Mukattash, T.; Alefishat, E. Public Perceptions About Home Delivery of Medication Service and Factors Associated with the Utilization of This Service. Patient Prefer. Adherence 2022, 16, 2259–2269. [Google Scholar] [CrossRef] [PubMed]
  27. Abu-Farha, R.; Alzoubi, K.H.; Mukattash, T.; Karout, S.; Itani, R.; I Nassar, R.; Barakat, M. Public perceptions about home delivery of medications service in Lebanon: A cross-sectional survey. Electron. J. Gen. Med. 2023, 20, em430. [Google Scholar] [CrossRef]
  28. Al-Zaidan, M.; Ibrahim, M.I.M.; Al-Kuwari, M.G.; Mohammed, A.M.; Mohammed, M.N.; Al Abdulla, S. Qatar’s Primary Health Care Medication Home Delivery Service: A Response Toward COVID-19. J. Multidiscip. Healthc. 2021, 14, 651–657. [Google Scholar] [CrossRef] [PubMed]
  29. Brey, Z.; Mash, R.; Goliath, C.; Roman, D. Home delivery of medication during Coronavirus disease 2019, Cape Town, South Africa: Short report. Afr. J. Prim. Health Care Fam. Med. 2020, 12, 2449. [Google Scholar] [CrossRef] [PubMed]
  30. Almaghaslah, D.; Alsayari, A.; Asiri, R.; AlBugami, N. Pharmacy workforce in Saudi Arabia: Challenges and opportunities: A cross-sectional study. Int. J. Health Plan. Manag. 2019, 34, e583–e593. [Google Scholar] [CrossRef]
Figure 1. Obstacles that may limit implementing home drug delivery services in Saudi Arabia.
Figure 1. Obstacles that may limit implementing home drug delivery services in Saudi Arabia.
Pharmacy 10 00162 g001
Table 1. Demographic characteristics of participated community pharmacy staff.
Table 1. Demographic characteristics of participated community pharmacy staff.
VariableFrequency (No.)Percent (%)
Age (years)
23–3471073.6
35–4421422.2
45–54333.4
55–6080.8
Gender
Male85488.5
Female11111.5
Nationality
Saudi23924.8
Non-Saudi72675.2
Region
Southern region17117.7
Eastern region818.4
Western region40141.6
Northern region12212.6
Central region19019.7
41.6% of the respondents reside in the
Educational level
Diploma121.2
Bachelor80082.9
Pharm.D12713.1
Master or PhD272.7
Professional classification
Consultant pharmacists313.2
Senior pharmacists24725.6
Pharmacists67770.2
Pharmacy technician101.1
Years of experience in the pharmacy work
<2 years16016.6
2–518919.6
6–1036037.3
>10 years25626.5
Table 2. Opinions and perceptions of community pharmacy staff towards home drug delivery.
Table 2. Opinions and perceptions of community pharmacy staff towards home drug delivery.
QuestionsYes (%)No (%)
If there is a consulting application, can the pharmacist provide remote consultations?879 (91%)86 (9%)
Can the pharmacist monitor the health of patients with chronic diseases in their homes?586 (61%)379 (39%)
Do you support the pharmacist to charge a fee for providing the pharmaceutical services delivery service?689 (72%)267 (28%)
Does drug delivery help patients to continue taking their medication?
Strongly disagree24 (2.5%)
Disagree 37 (3.8%)
Neutral 215 (22.3%)
Agree 414 (42.9%)
Strongly agree 275 (28.5%)
Are delivery apps a substitute for going to the hospital to collect treatment?
Never 123 (12.7%)
Rarely 56 (5.8%)
Sometimes 507 (52.5%)
Often 225 (23.3%)
Always 54 (5.6%)
Where do you prefer to Sale medicines?
Online 81 (8%)
In Pharmacy 884 (92%)
Who is the person qualified to provide and deliver pharmaceutical services? (Respondents may choose more than one answer)
Consultant pharmacists287 (29.7%)
Senior pharmacists342 (35.4%)
Pharmacists 688 (71.3%)
Pharmacy technicians385 (39.9%)
What are the most diseases that a pharmacist needs to be educated about when caring for patients? (Respondents may choose more than one answer)
Respiratory diseases 702 (72.7%)
Infectious diseases 688 (71.3%)
Heart diseases 618 (64.0%)
Liver and kidney disease441 (45.7%)
Endocrine disease438 (45.4%)
Psychological disease434 (44.9%)
Blood diseases400 (41.4%)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Algarni, M.A.; Alsheikh, M.Y.; Fathelrahman, A.I.; Alzaidi, M.S.; Faqeeh, F.J.; Althobaiti, A.M.; Alshahrani, A.M. Home Drug Delivery Service from the Perspective of Community Pharmacy Staff in Saudi Arabia. Pharmacy 2022, 10, 162. https://doi.org/10.3390/pharmacy10060162

AMA Style

Algarni MA, Alsheikh MY, Fathelrahman AI, Alzaidi MS, Faqeeh FJ, Althobaiti AM, Alshahrani AM. Home Drug Delivery Service from the Perspective of Community Pharmacy Staff in Saudi Arabia. Pharmacy. 2022; 10(6):162. https://doi.org/10.3390/pharmacy10060162

Chicago/Turabian Style

Algarni, Majed Ahmed, Mona Yaser Alsheikh, Ahmed Ibrahim Fathelrahman, Meshal Suwaylih Alzaidi, Fawaz Jilan Faqeeh, Abdulelah Mohammad Althobaiti, and Ali Mofleh Alshahrani. 2022. "Home Drug Delivery Service from the Perspective of Community Pharmacy Staff in Saudi Arabia" Pharmacy 10, no. 6: 162. https://doi.org/10.3390/pharmacy10060162

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop